Poliomyelitis: choosing the right vaccine for safer protection

Program towards eradication of Poliomyelitis in developing countries is moving rapidly. Eradication of wild poliovirus jPom the Western Pacific region was achieved in October 2000. The key to poliomyelitis eradication in the world lies in the Indian subcontinent, and if success is achieved there, er...

Full description

Bibliographic Details
Main Authors:	Narimak Awin, Raman Ismail
Format:	Article
Language:	English
Published:	Department Of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia 2005
Online Access:	http://journalarticle.ukm.my/4455/ http://journalarticle.ukm.my/4455/ http://journalarticle.ukm.my/4455/1/vol11-02ayiesah.pdf

id	ukm-4455
recordtype	eprints
spelling	ukm-44552016-12-14T06:36:04Z http://journalarticle.ukm.my/4455/ Poliomyelitis: choosing the right vaccine for safer protection Narimak Awin, Raman Ismail, Program towards eradication of Poliomyelitis in developing countries is moving rapidly. Eradication of wild poliovirus jPom the Western Pacific region was achieved in October 2000. The key to poliomyelitis eradication in the world lies in the Indian subcontinent, and if success is achieved there, eradication elsewhere becomes a matter of time. However, the use of OPV is frequently followed by sporadic or even epidemic vaccine - associated polio. There are 2 excellent polio vaccines available. OPV has served us well, but the time has come to ask whether the risk of imported disease is greater or lesser then the sporadic and occasionally epidemic OPV associated poliomyelitis. The tradeoff seems to be between the safety ofIPV and the secondary gain in immunization afforded by the spread of OP V strains to contacts. Public Health circumstances are not static when wild poliovirus strains were circulating abundantly, if made good sense to abort that circulation rapidly by the application of OPV. The cases of VAPP could be seen as the price that had to be paid in order to keep polio at bay. Now, in 2003, we face a different set of circumstances. Wild poliovirus no longer exist in the Western Pacific region and polio incidence is falling elsewhere. Therefore the substitution of IPV for OPV as has happened in North America and Europe, deserves new consideration for countries in this region including Malaysia. Department Of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia 2005 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/4455/1/vol11-02ayiesah.pdf Narimak Awin, and Raman Ismail, (2005) Poliomyelitis: choosing the right vaccine for safer protection. Jurnal Kesihatan Masyarakat, 11 (1). pp. 38-43. ISSN 1675-1663 http://www.communityhealthjournal.org/detailarticle.asp?id=338&issue=Vol11(1):2005
repository_type	Digital Repository
institution_category	Local University
institution	Universiti Kebangasaan Malaysia
building	UKM Institutional Repository
collection	Online Access
language	English
description	Program towards eradication of Poliomyelitis in developing countries is moving rapidly. Eradication of wild poliovirus jPom the Western Pacific region was achieved in October 2000. The key to poliomyelitis eradication in the world lies in the Indian subcontinent, and if success is achieved there, eradication elsewhere becomes a matter of time. However, the use of OPV is frequently followed by sporadic or even epidemic vaccine - associated polio. There are 2 excellent polio vaccines available. OPV has served us well, but the time has come to ask whether the risk of imported disease is greater or lesser then the sporadic and occasionally epidemic OPV associated poliomyelitis. The tradeoff seems to be between the safety ofIPV and the secondary gain in immunization afforded by the spread of OP V strains to contacts. Public Health circumstances are not static when wild poliovirus strains were circulating abundantly, if made good sense to abort that circulation rapidly by the application of OPV. The cases of VAPP could be seen as the price that had to be paid in order to keep polio at bay. Now, in 2003, we face a different set of circumstances. Wild poliovirus no longer exist in the Western Pacific region and polio incidence is falling elsewhere. Therefore the substitution of IPV for OPV as has happened in North America and Europe, deserves new consideration for countries in this region including Malaysia.
format	Article
author	Narimak Awin, Raman Ismail,
spellingShingle	Narimak Awin, Raman Ismail, Poliomyelitis: choosing the right vaccine for safer protection
author_facet	Narimak Awin, Raman Ismail,
author_sort	Narimak Awin,
title	Poliomyelitis: choosing the right vaccine for safer protection
title_short	Poliomyelitis: choosing the right vaccine for safer protection
title_full	Poliomyelitis: choosing the right vaccine for safer protection
title_fullStr	Poliomyelitis: choosing the right vaccine for safer protection
title_full_unstemmed	Poliomyelitis: choosing the right vaccine for safer protection
title_sort	poliomyelitis: choosing the right vaccine for safer protection
publisher	Department Of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia
publishDate	2005
url	http://journalarticle.ukm.my/4455/ http://journalarticle.ukm.my/4455/ http://journalarticle.ukm.my/4455/1/vol11-02ayiesah.pdf
first_indexed	2023-09-18T19:41:36Z
last_indexed	2023-09-18T19:41:36Z
_version_	1777405626994917376

Poliomyelitis: choosing the right vaccine for safer protection

Similar Items